Professional Bio
Dr. Ifthikharuddin has a special interest in the treatment of multiple myeloma and other plasma cell dyscrasias. He graduated from the Madras Medical College, India, followed by additional training in the United Kingdom, culminating in diplomas from the Royal College of Physicians (MRCP) and Hematology (MRC Path). He subsequently completed residency training in Internal Medicine and fellowship in Hematology/Oncology at The University of Rochester and joined the faculty in the year 2000. He is board certified in Hematology. In addition to clinical and teaching responsibilities, he is an active participant in several clinical trials.
Research Bio
Dr. Ifthikharuddin has a special interest in the treatment of multiple myeloma and other plasma cell dyscrasias. He graduated from the Madras Medical College, India, followed by additional training in the United Kingdom, culminating in diplomas from the Royal College of Physicians (MRCP) and Hematology (MRC Path). He subsequently completed residency training in Internal Medicine and fellowship in Hematology/Oncology at The University of Rochester and joined the faculty in the year 2000. He is board certified in Hematology. In addition to clinical and teaching responsibilities, he is an active participant in several clinical trials.
2011
Milner LA; Becker MW; Bernstein SH; Bruckner L; Friedberg JW; Holland GA; Ifthikharuddin JJ; LIesveld JL; Mathes EJ; Mechel HL; Mullen CA; Sasson T; Phillips GL 2nd. "Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease". Am J Hematology. 2011; 86(8): 712-714. |
2011
Liesveld JL; Rosell KE; Bechelli J; Lu C; Messina P; Mulford D; Ifthikharuddin JJ; Jordan CT; Phillips GL 2nd. "Proteasome inhibition in myelodysplastic syndromes and acute myelogeneous luekmia cell lines". Cancer Invest.. 2011; 29(7): 438-450. |
2008
Walker,AR; Komrokji, RS; Ifthikharuddin, JJ; Messina, P; Mulford, D; Becker, M; Friedberg, J; Oliva, J; Phillips, G; Liesveld, JL; Abboud, C. "Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (g-CSF) (CLAG regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML." Leukemia Research. 2008; 12(32): 1830-1836. |
2008
Phillips GL 2nd; Bernstein SH; Liesveld JL; Abboud CN; Becker MW; Constine LS; Ifthikharuddin JJ; Loughner JE; Milner LA; Vesole DH; Friedberg JW. "A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection". Leuk Res. 2008; 32(12): 1830-1836. |
2006 Apr 1
Zand MS, Vo T, Pellegrin T, Felgar R, Liesveld JL, Ifthikharuddin JJ, Abboud CN, Sanz I, Huggins J. "Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin." Blood. 2006 Apr 1; 107(7):2895-903. Epub 2005 Dec 20. |
